Nov. 26 at 5:38 PM
$CPIX $XBI $SQQQ $QQQ CPIX. Still waiting on the two P2 studies on Ifetroban for Sclerosis and Idiopathic Pulmonary Fibrosis. This doesn't include the P2 study OLE for 3 years that could also be released pending the end of phase 2 meeting with the FDA. There should be an update soon on the FDA meetings and plans for a P3 study on Ifetroban for DMD. Should pop it to
$6 or
$7. Just took longer than expected unfortunately. The MMers took it down in anticipation to accumulate over the last 2 weeks and now its starting to recover some. Patience.
